Fig. 9

Potential drug sensitivity analysis by IC50 and the immune checkpoint gene expression analysis between the high-risk and low-risk groups. (A) Boxplots showing the drug sensitivity analysis of commonly used chemotherapeutic agents in LSCC between high-risk and low-risk groups; (B) Violin showing expression of TIDE score between the high-risk and low-risk groups.